Stockholm, Sep. 24 - A new production line for the manufacturing of speciality fats for infant formula opened today at AAK´s factory in Karlshamn, Sweden.
AAK´s joint venture with Israeli biotech company, Enzymotec, has successfully introduced a range of fats within business area Food Ingredients, designed to meet the very specific demands from infant formula producers.
To meet the growing demand from global customers, AAK has invested in a significant expansion of production capacity. Construction is now completed and production has started.
“This 30 million SEK investment is an important step of our growth strategy. The new investment will give us a leading position in speciality fats for infant nutrition and provide a platform for further growth in this segment. Sales are increasing rapidly and we are pleased to announce the successful conclusion of this project”, said AAK president and CEO Jerker Hartwall.
“The organic growth specialization strategy is based on strong product development focused on, in particular, health promoting solutions. Selective acquisitions are complementing this strategy, and the acquisition of Croda Food Service in the area of Bakery and Rapsona (both business area Food Ingredients) came into effect in 2008 with a total turnover of approx 300 million SEK” said Jerker Hartwall.